Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03715036 · ClinicalTrials.gov registry record · NA
Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
NCT03715036 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 177 participants.
The verdict
NCT03715036, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
Study Summary
Abdominal circumference (AC) in the fetus is the single most useful indicator of fetal growth abnormalities. Measurement of AC as well as DVP do not require extensive training. Our objective is to evaluate if introduction of bedside ultrasound during routine antenatal visits to evaluate fetal AC and amniotic fluid DVP would decrease the false positive rates of fundal height measurement in diagnosing intrauterine growth abnormalities.
Interventions
- DIAGNOSTIC_TEST Point-of-care US
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2019-04-29 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03715036
The ClinicalTrials.gov registry entry for NCT03715036 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Point-of-care US is the first listed.
NCT03715036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03715036 about?
NCT03715036 is a clinical study titled "Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits". Abdominal circumference (AC) in the fetus is the single most useful indicator of fetal growth abnormalities. Measurement of AC as well as DVP do not require extensive training. Our objective is to evaluate if introduction of bedside ultrasound during routine antenatal visits to evaluate fetal AC and...
What is the current status of trial NCT03715036?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2019-04-29. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03715036?
The interventions under investigation include: Point-of-care US (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03715036?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.